Showing 1 - 2 results of 2 for search 'Bagepally BS', query time: 0.01s
Refine Results
-
1
-
2
Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective by Bagepally BS, Chaikledkaew U, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A
Published 2021Connect to this object online.
Book